Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 13, 2025
Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline
GlobeNewswire
·
March 13, 2025
– Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner – – Three INDs for wholly-owned programs expected in the next 3 years, …
The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results
GlobeNewswire
·
March 13, 2025
- Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 – SCOTTSDALE, Ariz., March 13, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: …
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 13, 2025
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescriber base, fill rates, and patient enrollments Secured $14.3 million net proceeds in financings, …
Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
GlobeNewswire
·
March 13, 2025
Momentum Builds Across Programs with Key Data Milestones Expected in 2025 Cemacabtagene Ansegedleucel (Cema-Cel): First-Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) Ongoing Pivotal Phase 2 ALPHA3 Trial Advancing with Site Activation and Patient …
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
GlobeNewswire
·
March 13, 2025
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT™ study reinforces its favorable safety profile. Publication in Science …
Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 13, 2025
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025 In parallel, the Company continues to analyze data and explore opportunities for LYR-210 in CRS patient cohort with nasal polyps …
Enhanced SAP metadata coverage capabilities for Safyr announced by Silwood Technology
EIN Presswire
·
March 13, 2025
Silwood have significantly increased Safyr's metadata coverage for SAP S/4HANA by harvesting metadata for SAP IDOCs, HANA Calculation Views and Internal Tables. ASCOT, BERKSHIRE, UNITED KINGDOM, March 13, 2025 /EINPresswire.com/ -- Silwood Technology …
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
GlobeNewswire
·
March 13, 2025
SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, announced today the …
‘The Star SEO': An Initiative To Meet the Growing Demand for Specialized SEO Services
EIN Presswire
·
March 13, 2025
DALLAS, TX, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- A holistic marketing approach, SEO is the result of thousands of tactile decisions, spanning specialities and web entities. North Rose Technologies, an industry-leading digital marketing …
HEART-VALVE-SURGERY.COM LAUNCHES NOVEL ROSS PROCEDURE PATIENT EDUCATION PLATFORM FOR AORTIC VALVE PATIENTS
EIN Presswire
·
March 13, 2025
LOS ANGELES, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, today launched the “Direct-to-Patient Ross Procedure Education Platform”, an end-to-end digital …
Dr. Eric Cornidez of Pain Institute of Southern Arizona Awarded As 2024 AZ Top Doc
EIN Presswire
·
March 13, 2025
Eric Cornidez, MD, MBA of Pain Institute of Southern Arizona has been reviewed and approved based on merit by AZ Top Docs for 2024. TUCSON, AZ, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Eric Cornidez, MD, MBA of Pain Institute of Southern …
Dr. Michael L. Goldberg Awarded As 2024 FL Top Doc
EIN Presswire
·
March 13, 2025
FL Top Docs has reviewed and approved Dr. Michael L. Goldberg of MedVantage Primary Care for 2024. BOYNTON BEACH, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- FL Top Docs has reviewed and approved Dr. Michael L. Goldberg of MedVantage …
Giants Hit It Out of the Park for Medically Complex Children at Spring Training Event in Scottsdale
EIN Presswire
·
March 13, 2025
A day of baseball joy and community support highlights Arizona’s Family LHA program and Team Select’s pediatric home care mission. SCOTTSDALE, AZ, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The San Francisco Giants opened their Spring Training …
Advocates Rallied in Record Numbers for Call-on Congress 2025
GlobeNewswire
·
March 13, 2025
Washington D.C., March 13, 2025 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization dedicated to ending colorectal cancer, brought together more than 300 survivors, caregivers, and loved ones for the 19th …
Immuno-Oncology Market is Predicted to Reach US$ 111.64 Billion by 2034, Expanding at a CAGR of 16.5% | Fact.MR
EIN Presswire
·
March 13, 2025
Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact.MR Report ROCKVILLE, MD, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The global immuno-oncology market is estimated to have a value of US$ 24.17 billion in …
Upper Extremity Implants Market Size, Report: 2033 Key Data – Data Analysis by Emergen Research
EIN Presswire
·
March 13, 2025
The upper extremity implants market is expected to grow from an estimated USD 1951.5 million in 2024 to USD 2826.0 million in 2033, with a CAGR of 4.20%. VANCOUVER, BC, CANADA, March 13, 2025 /EINPresswire.com/ -- The Upper Extremity Implants Market …
Alfa Chemistry Enriches Cosmetic Ingredients Supply: Antioxidants, Emulsifiers, UV-absorbers, and Preservatives Released
EIN Presswire
·
March 13, 2025
In a recent announcement, Alfa Chemistry reveals its plan to add more momentum to the beauty industry by adding more cosmetic ingredients to its portfolio. NY, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- In a recent announcement, Alfa Chemistry …
China Orthosis And Prosthetics Market Set to Witness Significant Growth by 2025-2032: Rehan International Co., Ltd
EIN Presswire
·
March 13, 2025
China orthosis and prosthetics market is estimated to be valued at US$ 1,740.1 Mn in 2023, and is expected to exhibit a CAGR of 5.3% by (2023-2030) BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire.com/ -- Latest Report, titled “China …
North America Vision Care Market Projected To Witness Substantial Growth, 2025-2032: Novartis AG, CooperVision, Inc
EIN Presswire
·
March 13, 2025
North America Vision Care market is estimated to be valued at US$ 6.44 Bn in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period 2023-2030 BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
China Scar Treatment Market Projected To Witness Substantial Growth, 2025-2032: Merz Pharma, Luca Pharmaceuticals
EIN Presswire
·
March 13, 2025
China scar treatment market is estimated to account for US$ 5,317.7 Mn in terms of value by the end of 2027. BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire.com/ -- Latest Report, titled “China Scar Treatment Market” Trends, Share, Size, …